IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Wacker’s Secretion Technology Studied

May 26, 2008 | Deepti Ramesh

Wacker Biotech (Jena, Germany), a wholly owned subsidiary of Wacker Chemie, says it has completed a feasibility study demonstrating that the company’s secretion technology can produce active protein comparable to that produced by mammalian cell cultures. “We believe the positive results of this study demonstrate that secreting E. coli systems can be a great tool for producing biologics in the future,” says Thomas Maier, managing director of Wacker Biotech. The study was aimed at determining the company’s efficacy of proprietary E. coli...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa